Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycoplasma pneumoniae infections.

M R Hammerschlag1

  • 1Department of Pediatrics, SUNY Downstate Medical Center, Brooklyn, New York 11203-2098, USA. mhammerschlag@pol.net

Current Opinion in Infectious Diseases
|April 30, 2002
PubMed
Summary

Mycoplasma pneumoniae causes respiratory infections, but diagnosing it is challenging due to a lack of rapid, standardized tests. Accurate detection often requires combining PCR and serology for effective community-acquired pneumonia management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chlamydia pneumoniae Induces Interferon Gamma Responses in Peripheral Blood Mononuclear Cells in Children with Allergic Asthma.

Scandinavian journal of immunology·2017
Same author

Chlamydia pneumoniae induces interleukin-12 responses in peripheral blood mononuclear cells in asthma and the role of toll like receptor 2 versus 4: a pilot study.

Irish journal of medical science·2016
Same author

Increased seroprevalence of Enterovirus 71 IgE antibodies in asthmatic compared with non-asthmatic children.

Irish journal of medical science·2016
Same author

Chlamydia trachomatis respiratory infection in Dutch infants.

Archives of disease in childhood·2009
Same author

In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.

Antimicrobial agents and chemotherapy·2004
Same author

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.

The Journal of antimicrobial chemotherapy·2001

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Mycoplasma pneumoniae is a significant cause of community-acquired respiratory infections.
  • Its prevalence in pneumonia varies widely (1.9-30%) based on diagnostic methods and populations studied.
  • Outbreaks occur in institutional settings, highlighting transmission risks.

Purpose of the Study:

  • To review current diagnostic methods for Mycoplasma pneumoniae infections.
  • To assess the performance and limitations of available diagnostic assays.
  • To evaluate treatment efficacy in the context of diagnostic challenges.

Main Methods:

  • Review of recent literature on Mycoplasma pneumoniae diagnostics and treatment.
  • Analysis of studies employing polymerase chain reaction (PCR) and serological assays.

Related Experiment Videos

  • Examination of outbreak investigations requiring combined diagnostic approaches.

    • Main Results:

    • Standardized, rapid diagnostic methods for Mycoplasma pneumoniae are lacking.
    • Accurate diagnosis can necessitate a combination of PCR and serology.
    • Limited data exist on the microbiological efficacy of recommended antibiotics due to diagnostic inconsistencies.

    Conclusions:

    • The absence of reliable, rapid diagnostic tests necessitates empirical treatment for Mycoplasma pneumoniae pneumonia.
    • Further standardization of diagnostic assays is crucial for accurate prevalence assessment and treatment evaluation.
    • Improved diagnostic capabilities are needed to guide targeted antimicrobial therapy.